Martigny, Switzerland

Bertrand Ducrey

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: Bertrand Ducrey: Innovator in Pharmaceutical Composition

Introduction

Bertrand Ducrey is a notable inventor based in Martigny, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of slow-release compositions. His innovative work has led to the creation of a unique patent that addresses the challenges of drug delivery.

Latest Patents

Ducrey holds a patent for a slow-release pharmaceutical composition made of microgranules. This composition is designed for the slow release of an active substance over a period that covers at least six months after injection. The formulation includes microparticles made from a copolymer of the PLGA type, which incorporates a water-insoluble peptide salt. The copolymer consists of at least 75% lactic acid and has an inherent viscosity between 0.1 and 0.9 dl/g. The microparticles have a specific size distribution, ensuring effective delivery of the active substance.

Career Highlights

Throughout his career, Bertrand Ducrey has worked with prominent companies in the pharmaceutical industry. He has been associated with Debiopharm Research & Manufacturing SA and Debiopharm International SA. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Ducrey has collaborated with notable professionals in his field, including Patrick Garrouste and Catherine Curdy. These collaborations have further enhanced his work and contributed to advancements in pharmaceutical compositions.

Conclusion

Bertrand Ducrey is a distinguished inventor whose work in slow-release pharmaceutical compositions has made a significant impact in the field. His innovative approach and collaborations with industry professionals continue to influence pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…